BENTONVILLE, Ark. – Walmart announced the opening of 25 new autoimmune-focused Specialty Pharmacies of the Community across five states as part of a continued journey toward improving health outcomes for all. These 25 new locations come after debuting six last October.
ALEXANDRIA, Va. – The Pharmacy Quality Alliance (PQA) has received a 2024 Power of Associations Gold Award from the American Society of Association Executives (ASAE) for the PQA Diverse Quality Leaders Program.
Walmart Health Center locations in Florida, Georgia, Missouri and Texas are slated to become senior-focused primary care centers, Humana Inc.’s CenterWell health care services announced on Wednesday.
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today praised a report on pharmacy benefit manager (PBM) middlemen issued by House Oversight and Accountability Committee Chairman James Comer (R-KY).
ALEXANDRIA, Va. – The National Community Pharmacists Association released the following statement today from its CEO, B.
CVS Caremark today announced a renewed pledge to American businesses, unions, and health plans — building on what the company is doing to deliver greater transparency, lower drug costs, and better clinical care for the most utilized health benefit.
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application for dutasteride and tamsulosin hydrochloride capsules 0.5 mg/0.4 mg.
EAST WINDSOR, N.J. – Aurobindo Pharma has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application baricitinib tablets, 1mg and 2mg.
ARLINGTON, Va. – The National Association of Chain Drug Stores (NACDS) today hailed the U.S.
Manufacturing, distributing and delivering cold chain pharmaceuticals poses unique challenges and opportunities for the healthcare supply chain.
The Pharmaceutical Care Management Association (PCMA) released the following statement ahead of the U.S.
Walgreens has received a project award valued up to $25 million through the Rapid Response Partnership Vehicle (RRPV) to conduct a Phase IV observational clinical study focused on assessing Correlates of Protection (CoP), known as responses to a vaccine that predict how well a vaccinated person will
A coalition of organizations representing pharmacies and pharmacists across all practice settings released a statement today ahead of a Tuesday, July 23 U.S.
EAST WINDSOR, N.J. – Aurobindo Pharma Limited has received final approval from U.S. Food and Drug Administration for its Abbreviated New Drug Application posaconazole delayed-release tablets 100mg.
